Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review

Linehan AS, Fitzpatrick OM, Morris PG

Breast Cancer: Targets and Therapy 2021, 13:151-159

Published Date: 25 February 2021